Krishna Institute of Medical Sciences Balance Sheet Health
Financial Health criteria checks 2/6
Krishna Institute of Medical Sciences has a total shareholder equity of ₹22.8B and total debt of ₹14.5B, which brings its debt-to-equity ratio to 63.7%. Its total assets and total liabilities are ₹45.8B and ₹23.0B respectively. Krishna Institute of Medical Sciences's EBIT is ₹5.4B making its interest coverage ratio 8.5. It has cash and short-term investments of ₹902.0M.
Key information
63.7%
Debt to equity ratio
₹14.54b
Debt
| Interest coverage ratio | 8.5x |
| Cash | ₹902.00m |
| Equity | ₹22.83b |
| Total liabilities | ₹22.96b |
| Total assets | ₹45.79b |
Recent financial health updates
Recent updates
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Dec 09
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 13There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Sep 05We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Aug 23Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Jul 02Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08Financial Position Analysis
Short Term Liabilities: KIMS's short term assets (₹6.3B) do not cover its short term liabilities (₹6.6B).
Long Term Liabilities: KIMS's short term assets (₹6.3B) do not cover its long term liabilities (₹16.4B).
Debt to Equity History and Analysis
Debt Level: KIMS's net debt to equity ratio (59.7%) is considered high.
Reducing Debt: KIMS's debt to equity ratio has increased from 51.7% to 63.7% over the past 5 years.
Debt Coverage: KIMS's debt is well covered by operating cash flow (34.1%).
Interest Coverage: KIMS's interest payments on its debt are well covered by EBIT (8.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 18:10 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Krishna Institute of Medical Sciences Limited is covered by 22 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Prashant Nair | Ambit Capital |
| null null | Anand Rathi Shares and Stock Brokers Limited |